Mass spectrometry-based proteogenomic investigation of protein-protein interaction networks and cancer-related pathways associated with NSCLC patients' EGFRm (+/-) status

Mass spectrometry-based proteogenomic investigation of protein-protein interaction networks and cancer-related pathways associated with NSCLC patients' EGFRm (+/-) status - MS-based Proteogenomic study on molecular networks associated with EGFRm (+/-) status

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026803

Enrollment

Registered

2017-04-10

Start date

2017-04-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer (NSCLC)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases which were diagnosed pathologically a primary lung adenocarcinoma and the presence or absence of EGFR mutation was clarified. Eastern Cooperative Oncology Group (ECOG)PS: 0 to 2

Exclusion criteria

Exclusion criteria: The case where patient's consent was withdrawn.

Design outcomes

Primary

Measure	Time frame
Identification of disease-related expressed proteins associated with the presence or absence of EGFR mutation and extraction of their molecular interaction networks	—

Countries

Japan

Contacts

Public ContactAtsuko Shimamura

St. Marianna University School of Medicine Translational Medicine Informatics

shimamura@marianna-u.ac.jp044-977-8111

Outcome results